FI74009B - FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 2-carboxylate. - Google Patents

FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 2-carboxylate.

Info

Publication number
FI74009B
FI74009B FI831135A FI831135A FI74009B FI 74009 B FI74009 B FI 74009B FI 831135 A FI831135 A FI 831135A FI 831135 A FI831135 A FI 831135A FI 74009 B FI74009 B FI 74009B
Authority
FI
Finland
Prior art keywords
therapeutic
carboxylate
measure
frequency requirement
therapeutic use
Prior art date
Application number
FI831135A
Other languages
Finnish (fi)
Other versions
FI831135L (en
FI74009C (en
FI831135A0 (en
Inventor
Choung Un Kim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI831135A0 publication Critical patent/FI831135A0/en
Publication of FI831135L publication Critical patent/FI831135L/en
Application granted granted Critical
Publication of FI74009B publication Critical patent/FI74009B/en
Publication of FI74009C publication Critical patent/FI74009C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI831135A 1982-04-08 1983-04-05 FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 2-carboxylate. FI74009C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08
US36662782 1982-04-08

Publications (4)

Publication Number Publication Date
FI831135A0 FI831135A0 (en) 1983-04-05
FI831135L FI831135L (en) 1983-10-09
FI74009B true FI74009B (en) 1987-08-31
FI74009C FI74009C (en) 1987-12-10

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831135A FI74009C (en) 1982-04-08 1983-04-05 FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 2-carboxylate.

Country Status (25)

Country Link
JP (1) JPS58188887A (en)
KR (1) KR880001055B1 (en)
AT (1) AT383126B (en)
AU (1) AU567092B2 (en)
BE (1) BE896407A (en)
CA (1) CA1198440A (en)
CH (1) CH661927A5 (en)
DE (1) DE3312517A1 (en)
DK (1) DK155983A (en)
ES (1) ES521224A0 (en)
FI (1) FI74009C (en)
FR (1) FR2524888B1 (en)
GB (1) GB2118183B (en)
GR (1) GR78822B (en)
HU (1) HU190716B (en)
IE (1) IE55225B1 (en)
IL (1) IL68295A0 (en)
IT (1) IT1168854B (en)
LU (1) LU84739A1 (en)
MY (1) MY8700945A (en)
NL (1) NL8301193A (en)
OA (1) OA07395A (en)
PT (1) PT76518B (en)
SE (1) SE460197B (en)
ZA (1) ZA832411B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (en) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Process for the preparation of novel carbapenem derivatives
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
DK165280A (en) * 1979-04-19 1980-10-20 Merck & Co Inc PROCEDURE FOR PREPARING 2- AND 6-SUBSTITUTED 1-CARBADETHIAPEN-2-EM-3-CARBOXYLIC ACIDS AND INTERMEDIATES FOR USE IN THE PRESENTATION OF THE PROCEDURE
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
AU567092B2 (en) 1987-11-12
IL68295A0 (en) 1983-07-31
SE8301928L (en) 1983-12-02
IE55225B1 (en) 1990-07-04
CA1198440A (en) 1985-12-24
LU84739A1 (en) 1983-12-05
DE3312517C2 (en) 1991-10-31
BE896407A (en) 1983-10-07
IE830800L (en) 1983-10-08
FI831135L (en) 1983-10-09
FI74009C (en) 1987-12-10
ES8405399A1 (en) 1984-06-01
ATA125583A (en) 1986-10-15
ZA832411B (en) 1983-12-28
IT8348061A0 (en) 1983-04-07
NL8301193A (en) 1983-11-01
CH661927A5 (en) 1987-08-31
DK155983A (en) 1983-10-09
FR2524888B1 (en) 1985-12-13
PT76518B (en) 1986-02-06
IT1168854B (en) 1987-05-20
ES521224A0 (en) 1984-06-01
HU190716B (en) 1986-10-28
JPS58188887A (en) 1983-11-04
GB2118183B (en) 1985-11-27
AT383126B (en) 1987-05-25
GB2118183A (en) 1983-10-26
MY8700945A (en) 1987-12-31
GR78822B (en) 1984-10-02
DK155983D0 (en) 1983-04-07
SE460197B (en) 1989-09-18
DE3312517A1 (en) 1983-10-20
KR840004429A (en) 1984-10-15
OA07395A (en) 1984-06-30
FR2524888A1 (en) 1983-10-14
PT76518A (en) 1983-05-01
AU1319883A (en) 1983-10-13
FI831135A0 (en) 1983-04-05
JPH0524156B2 (en) 1993-04-06
GB8309505D0 (en) 1983-05-11
SE8301928D0 (en) 1983-04-07
KR880001055B1 (en) 1988-06-18

Similar Documents

Publication Publication Date Title
NO811731L (en) PROCEDURE FOR THE PREPARATION OF IMIDAZO-RIFAMYCIN DERIVATIVES
NO813678L (en) PROCEDURE FOR THE PREPARATION OF CARBOSTYRIC DERIVATIVES
NO831873L (en) PROCEDURE FOR THE PREPARATION OF NEW ALKAN AND ALKENDER DERIVATIVES
IT1140568B (en) CIRCUIT FOR MEASURING IMPEDANCE
NO831610L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXICAM DERIVATIVES.
NO814065L (en) PROCEDURE FOR THE PREPARATION OF IMIDAZOLYLPHENYLAMIDINES
NO844243L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE RELATIONS
FI821910A0 (en) ANORDINATION FOR DELIVERY OF STROCHES
NO820281L (en) PROCEDURE FOR THE PREPARATION OF N- (HALOGENMETHYL) -ACYLAMIDES
FI820598L (en) PROCEDURE FOR THE FRAMSTATION OF TREO-2-HYDROXY-3- (4-METHOXIFENYL) -3- (2-NITROPHENYLTHIO) -PROPIONSYRAESTER
NO833527L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENYL-CYCLOBUTYL DERIVATIVES
FI74009B (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC USE OF THERAPEUTIC MEASURE 2-carboxylate.
FI833648A0 (en) PROCEDURE FOR FRAMSTATION OF AV 4-METHYL-5-ALKYLTHIOMETHYLIMIDAZOLER
NO813263L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLON DERIVATIVES
NO834437L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SPIRO-3-HETERO-AZOLON DERIVATIVES
NO831995L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N- (2-METOXYTHYL) -NOROXYMORPHONE
NO831874L (en) PROCEDURE FOR THE PREPARATION OF TRIFENYLBUTEN DERIVATIVES
NO812842L (en) PROCEDURE FOR THE PREPARATION OF AMINOACETONITIL DERIVATIVES
NO153100C (en) PROCEDURE FOR THE PREPARATION OF N- (HALOGENMETHYL) -ACYLAMIDES.
NO812937L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE N- (1-ALLYL-2-PYRROLIDINYL-METHYL) -2-METHOXY-4-AMINO-5-METHYLSULPHAMOYL-BENZAMIDE
FI820510L (en) FOERFARANDE OCH ANORDNING FOER CALIBRATION AV EN MAETANORDNING AVSEDD FOER MAETNING AV DIMENSIONEN HOS EN KROPP
NO811134L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIAZOL DERIVATIVES.
IT1170713B (en) PIPERAZIN COMPOUNDS PROCEDURE FOR PREPARING AND USING THEM
FI803320L (en) PROCEDURE FOR FRAMSTAELLNING AV / 1- (4-CHLORBENZOYL) -5-METHOXY-2-METHYL-3-INDOL / ACETOXYETHYXIDE
IT1193383B (en) PROCEDURE FOR THE DEALOGENATION OF ETERI

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO